These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 2237825

  • 1. Effects of calcium channel blockers on platelet aggregation and thromboxane A2 formation: an in vivo double blind randomized study.
    Rostagno C, Prisco D, Paniccia R, Costanzo G, Poggesi L, Boddi M, Abbate R.
    Thromb Res; 1990 Aug 01; 59(3):531-9. PubMed ID: 2237825
    [Abstract] [Full Text] [Related]

  • 2. In vitro effects of two novel calcium antagonists (nitrendipine and nisoldipine) on intraplatelet calcium redistribution, platelet aggregation and thromboxane A2 formation. Comparison with diltiazem, nifedipine and verapamil.
    Rostagno C, Abbate R, Gensini GF, Coppo M, Prisco D, Boddi M, Neri Serneri GG.
    Thromb Res; 1991 Aug 15; 63(4):457-62. PubMed ID: 1754998
    [No Abstract] [Full Text] [Related]

  • 3. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
    Johnson GJ, Leis LA, Francis GS.
    Circulation; 1986 Apr 15; 73(4):847-54. PubMed ID: 3004784
    [Abstract] [Full Text] [Related]

  • 4. Antithrombogenic effects of calcium channel blockers: synergism with prostacyclin and thromboxane synthase inhibitors.
    Onoda JM, Sloane BF, Honn KV.
    Thromb Res; 1984 Jun 01; 34(5):367-78. PubMed ID: 6377570
    [Abstract] [Full Text] [Related]

  • 5. Adenosine potentiates the inhibitory effects of calcium channel antagonists on human platelet aggregation induced by thromboxane A2 or U46619.
    Johnson GJ, Leis LA, Francis GS.
    Thromb Res; 1990 Jul 01; 59(1):139-48. PubMed ID: 2399526
    [Abstract] [Full Text] [Related]

  • 6. Inhibitory effects of endothelial cells and calcium channel blockers on platelet aggregation.
    Yamada Y, Furui H, Furumichi T, Suzuki T, Yamauchi K, Yokota M, Hayashi H, Saito H.
    Jpn Heart J; 1990 Mar 01; 31(2):201-15. PubMed ID: 2113109
    [Abstract] [Full Text] [Related]

  • 7. Influence of calcium-channel blockers on platelet function and arachidonic acid metabolism.
    Mehta JL.
    Am J Cardiol; 1985 Jan 25; 55(3):158B-164B. PubMed ID: 2982252
    [Abstract] [Full Text] [Related]

  • 8. Calcium channel blocker treatment of tumor cells induces alterations in the cytoskeleton, mobility of the integrin alpha IIb beta 3 and tumor-cell-induced platelet aggregation.
    Timar J, Chopra H, Rong X, Hatfield JS, Fligiel SE, Onoda JM, Taylor JD, Honn KV.
    J Cancer Res Clin Oncol; 1992 Jan 25; 118(6):425-34. PubMed ID: 1377695
    [Abstract] [Full Text] [Related]

  • 9. [Inhibition of platelet aggregation and thromboxane formation by the calcium antagonist nisoldipine following a single oral dose of 10 mg. A double-blind study in healthy probands].
    Schrör K, Latta G, Darius H, Klaus W, Ziegler R.
    Klin Wochenschr; 1985 Jan 02; 63(1):16-9. PubMed ID: 3838352
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of rabbit platelet phosphodiesterase activity and aggregation by calcium channel blockers.
    Moore JB, Fuller BL, Falotico R, Tolman EL.
    Thromb Res; 1985 Nov 01; 40(3):401-11. PubMed ID: 2417362
    [Abstract] [Full Text] [Related]

  • 11. Effects of diltiazem and verapamil on ADP-induced rabbit platelet shape change and aggregation.
    Dehpour AR, Samadian T, Akhavan MM, Meysamee F, Delfan A.
    Gen Pharmacol; 1995 Oct 01; 26(6):1295-9. PubMed ID: 7590122
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of platelet aggregation by diltiazem. Comparison with verapamil and nifedipine and inhibitory potencies of diltiazem metabolites.
    Kiyomoto A, Sasaki Y, Odawara A, Morita T.
    Circ Res; 1983 Feb 01; 52(2 Pt 2):I115-9. PubMed ID: 6831645
    [Abstract] [Full Text] [Related]

  • 13. Dual effects of nimesulide, a COX-2 inhibitor, in human platelets.
    Saeed SA, Afzal MN, Shah BH.
    Life Sci; 1998 Feb 01; 63(20):1835-41. PubMed ID: 9820127
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of platelet-activating factor binding to human platelets by calcium channel blockers.
    Valone FH.
    Thromb Res; 1987 Mar 01; 45(5):427-35. PubMed ID: 3590086
    [Abstract] [Full Text] [Related]

  • 15. Effects of verapamil on platelet aggregation, ATP release and thromboxane generation.
    Mehta J, Mehta P, Ostrowski N, Crews F.
    Thromb Res; 1983 Jun 01; 30(5):469-75. PubMed ID: 6612680
    [Abstract] [Full Text] [Related]

  • 16. Membrane activity, antioxidant, antiaggregatory and antihemolytic properties of four calcium channel blockers.
    Robak J, Duniec Z.
    Pharmacol Res Commun; 1986 Dec 01; 18(12):1107-17. PubMed ID: 3562505
    [Abstract] [Full Text] [Related]

  • 17. Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies.
    Jones CR, Pasanisi F, Elliott HL, Reid JL.
    Br J Clin Pharmacol; 1985 Sep 01; 20(3):191-6. PubMed ID: 2994701
    [Abstract] [Full Text] [Related]

  • 18. Effects of verapamil and diltiazem on human platelet function.
    Addonizio VP, Fisher CA, Strauss JF, Wachtfogel YT, Colman RW, Josephson ME.
    Am J Physiol; 1986 Mar 01; 250(3 Pt 2):H366-71. PubMed ID: 3006516
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of human platelet aggregation and cytoplasmic calcium response by calcium antagonists: studies with aequorin and quin2.
    Ware JA, Johnson PC, Smith M, Salzman EW.
    Circ Res; 1986 Jul 01; 59(1):39-42. PubMed ID: 3089642
    [Abstract] [Full Text] [Related]

  • 20. Effect of calcium channel blockers on platelet GPIIb-IIIa as a calcium channel in liposomes: comparison with effects on the intact platelet.
    Rybak ME, Renzulli LA.
    Thromb Haemost; 1992 Jan 23; 67(1):131-6. PubMed ID: 1319614
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.